999久久久国产精品,亚洲精品无码一区二区卧室 ,亚洲精品久久久蜜桃,免费观看的国产大片app下载

上海非利加實業(yè)有限公司Logo

熱門詞: 進口電動溫度調節(jié)閥結構圖|進口電動溫度調節(jié)閥數(shù)據(jù)表進口電動高溫調節(jié)閥-德國進口電動高溫法蘭調節(jié)閥進口電動蒸汽調節(jié)閥-德國進口電動蒸汽調節(jié)閥

當前位置: 首頁 > 所有品牌 > QuatRx
QuatRx
QuatRx QuatRx

QuatRx Pharmaceuticals 
QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. We currently have four product candidates in clinical development. Our two lead compounds, Ophena? and fispemifene, treat hormone deficiencies that result from aging in women and men.

Ophena? (ospemifene), our treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women, is in a second Phase III pivotal study having successfully completed an initial pivotal Phase III study.

Fispemifene, our treatment for testosterone deficiency and other conditions in men, is in Phase II clinical testing.

Sobetirome (QRX-431), our product candidate for the treatment of dyslipidemia, is in Phase I clinical testing.

Asord? (becocalcidiol), our topical product candidate for the treatment of psoriasis, is in Phase II clinical trials through our licensee Galderma.

Our management team has extensive experience in pharmaceutical development, particularly in endocrine and cardiovascular therapies, having participated in over 60 clinical development programs in their careers. Our management team has contributed to over 30 programs involving approved drugs, ten of which reached annual sales in excess of $1 billion and include the world’s best selling pharmaceutical product, Lipitor.

 

關于我們客戶服務產品分類法律聲明